Navigation Links
Flextronics Announces Change in Control Repurchase Offer for Solectron's 0.50% Senior Convertible Notes
Date:10/31/2007

SINGAPORE, Oct. 31 /PRNewswire-FirstCall/ -- Flextronics International Ltd. (Nasdaq: FLEX) today announced that, in connection with Flextronics's previously announced acquisition of Solectron Corporation on October 1, 2007, Solectron has notified holders of its outstanding 0.50% Convertible Senior Notes due 2034 (CUSIP Nos. 834182 AR 8 and 834182 AS 6) and Solectron's 0.50% Convertible Senior Notes Series B due 2034 (CUSIP No. 834182 AT) (together, the "Convertible Notes") that it will repurchase any Convertible Notes delivered for repurchase pursuant to its offer to repurchase at a cash price equal to 100% of their outstanding principal amount, plus accrued and unpaid interest to, but excluding, the date of repurchase. The indentures governing the Convertible Notes require Solectron to make the offer to repurchase the Convertible Notes as a result of Flextronics's acquisition of Solectron.

U.S. Bank National Association is acting as the paying agent for Solectron's offer to repurchase its Convertible Notes (the "Paying Agent").

In order to have their Convertible Notes repurchased, holders must validly surrender their Convertible Notes to the Paying Agent by 5:00 p.m., New York City time, on November 30, 2007 (the "Submission Deadline"). The repurchase price for all Convertible Notes validly surrendered and not withdrawn by the Submission Deadline shall become due and payable on December 14, 2007 and interest on such Convertible Notes will cease to accrue on and after such date. Solectron will deposit a cash payment equal to the aggregate repurchase price for the Convertible Notes being repurchased with the Paying Agent, which will transmit payments to holders.

The Convertible Notes, which are convertible into a cash payment of $402.41 per $1,000 principal amount, are not currently convertible and Solectron makes no assurances that the Convertible Notes will become convertible again at any time prior to their maturity on February 15, 2034.

Holders of Convertible Notes should carefully read the Change in Control Repurchase Notice issued by Solectron, as it contains important information regarding the procedures to be followed and timing for Solectron's repurchase of the Convertible Notes. Holders of Convertible Notes may obtain copies of the Change in Control Repurchase Notice and delivery instructions for the Convertible Notes by contacting U.S. Bank National Association at (800) 934-6802.

About Flextronics

Headquartered in Singapore (Singapore Reg. No. 199002645H), Flextronics is a leading Electronics Manufacturing Services (EMS) provider focused on delivering complete design, engineering and manufacturing services to automotive, computing, consumer digital, industrial, infrastructure, medical and mobile OEMs. With the acquisition of Solectron, pro forma fiscal year 2007 revenues from continuing operations are more than US$30.0 billion. Flextronics helps customers design, build, ship, and service electronics products through a network of facilities in 35 countries on four continents. This global presence provides design and engineering solutions that are combined with core electronics manufacturing and logistics services, and vertically integrated with components technologies, to optimize customer operations by lowering costs and reducing time to market. For more information, please visit http://www.flextronics.com.


'/>"/>
SOURCE Flextronics International Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 2016 , ... The Wickman Agency in Garland, TX has ... community. Pledging to select a new beneficiary every 60 days, the agency will ... is to bring community awareness to important local causes by forming campaigns which ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. Peyman Ghasri, skin ... a variety of comprehensive procedures for facial enhancement. The treatments now available at ... enhancement and nasal reshaping. , As a result, patients can improve virtually ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s ... together more than 200 of the country’s top healthcare executives to share insights ... true benefit of the Forum is the provider-centric perspective, experience, expertise and strategy ...
(Date:2/10/2016)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral ... December 31, 2015 on Monday, February 29, 2016 after the market closes. , The ... release at 4:30 PM ET. Investors interested in participating by phone are invited to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric therapists ... their patients. Research shows that the Goal Attainment Scale (GAS) captures 20% more ... challenge and learn more about the Goal Attainment Scale, Education Resources Inc. is ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Feb. 9, 2016 On Tuesday, ... (FDA) met with its Arthritis Advisory Committee ... of Johnson & Johnson,s Remicade and most ... in the U.S. The Biologics Prescribers Collaborative ... - Alliance for Patient Access, American Association ...
(Date:2/10/2016)... 2016 Demonstrates changes in ... receptor selectivity   1 receptor ... entered clinical development as a new treatment for ...   --> 1 receptor agonist, ... clinical development as a new treatment for cognitive ...
(Date:2/9/2016)... Corporation (NASDAQ: PODD ) (Insulet or the Company), the ... OmniPod ® Insulin Management System, today announced ... Insulet,s Board of Directors. With his appointment, the Board is ... --> --> Mr. Lemoine ... a deep knowledge of accounting, financial reporting and internal controls ...
Breaking Medicine Technology: